A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity

Completed

Phase 3 Results

Main Contacts

Name Phone E-mail
GSK Clinical Trials Study Director

Other Locations

Name City State Country Status
GSK Investigational Site Guangzhou Guangdong China Unknown_status_icon
GSK Investigational Site Haerbin Heilongjiang China Unknown_status_icon
GSK Investigational Site Wuhan Hubei China Unknown_status_icon
GSK Investigational Site Nanjing Jiangsu China Unknown_status_icon
GSK Investigational Site Suzhou Jiangsu China Unknown_status_icon
GSK Investigational Site Shenyang Liaoning China Unknown_status_icon
GSK Investigational Site Chengdu Sichuan China Unknown_status_icon
GSK Investigational Site Beijing China Unknown_status_icon
GSK Investigational Site Beijing China Unknown_status_icon
GSK Investigational Site Beijing China Unknown_status_icon
GSK Investigational Site Hangzhou China Unknown_status_icon
GSK Investigational Site Shanghai China Unknown_status_icon
GSK Investigational Site Shanghai China Unknown_status_icon